SGLT-2 inhibition in IgA nephropathy: the new standard of care?

After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy.

(2020) Thomas Rauen et al.   KIDNEY INTERNATIONAL

Dapagliflozin in Patients with Chronic Kidney Disease

(2020) Hiddo J.L. Heerspink et al.   NEW ENGLAND JOURNAL OF MEDICINE

Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

(2019) Jürgen Floege et al.   KIDNEY INTERNATIONAL

Evaluating a New International Risk-Prediction Tool in IgA Nephropathy

(2019) Sean J. Barbour et al.   JAMA Internal Medicine

Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy

(2017) Jicheng Lv et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Intensive Supportive Care plus Immunosuppression in IgA Nephropathy

(2015) Thomas Rauen et al.   NEW ENGLAND JOURNAL OF MEDICINE